Evidence map›Paper›PMID 7527557›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

G Sauvageau, P M Lansdorp, C J Eaves, D E Hogge, W H Dragowska, D S Reid, C Largman, H J Lawrence, R K Humphries

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 177 papers.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 509 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Regulation of HOX gene expression in AML.Blood cancer journal · 2024
    Review
  8. HOXA9 Regulome and Pharmacological Interventions in Leukemia.Advances in experimental medicine and biology · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

G SauvageauTerry Fox Laboratory, British Columbia Cancer Agency, Canada.
P M Lansdorp
C J Eaves
D E Hogge
W H Dragowska
D S Reid
C Largman
H J Lawrence
R K Humphries
BC Cancer Agency · CA

Funding

PROLIFERATION OF PURIFIED HEMATOPOIETIC STEM CELLSR01AI029524 · NIAID · UNIVERSITY OF BRITISH COLUMBIA · PI LANSDORP, PETER M · 1990 to 2006
$958k
ACTIVATION OF PURIFIED HEMATOPOIETIC STEM CELLSR21AI029524 · NIAID · UNIVERSITY OF BRITISH COLUMBIA · PI LANSDORP, PETER M · 1997 to 1997
–
NIAID NIH HHS AI-29524
6 · The paper itself

Abstract

Class I homeobox (Hox) genes encode a major group of transcription factors controlling embryonic development and have been implicated in the continuing process of hematopoietic cell differentiation. They are clustered on four chromosomes and, in early development, exhibit spatially restricted expression with respect to their 3'-->5' chromosomal position. By using an improved PCR-based method for amplifying total cDNA derived from limited cell numbers, we now describe the expression of class I Hox genes in highly purified CD34+ cell subpopulations isolated from normal human bone marrow that represent functionally distinct stem and progenitor cell compartments. Our data indicate that at least 16 different Hox genes, mainly from the A and the B clusters, are expressed in one or more of these subpopulations of human hematopoietic cells. Moreover, markedly elevated expression of some of the Hox genes found at the 3' end of the A and B clusters (e.g., HoxB3) was a unique feature of the subpopulations that contained the most primitive functionally defined cells, whereas genes located in the 5' region of each cluster (e.g., HoxA10) were found to be expressed at nearly equal levels in the CD34+ subpopulations analyzed. In contrast to the findings for CD34+ cells, expression of two selected Hox genes, HoxB3 and HoxA10, was virtually extinguished in the CD34- fraction of bone marrow cells. These results demonstrate the expression of a broad range of Hox genes in primitive hematopoietic cells and point to the existence of a regulated program of Hox gene expression during their normal development.

Indexed as

Antigens, CDGene ExpressionGenes, HomeoboxAntigens, CD34Base SequenceBone MarrowBone Marrow CellsCell DivisionColony-Forming Units AssayDNA, ComplementaryDNA PrimersFlow CytometryGene Expression RegulationHematopoietic Stem CellsHumansMolecular Sequence DataAntigens, CDAntigens, CD34DNA, ComplementaryDNA Primers

Identifiers

PMID7527557
PMCPMC45409
OpenAlexW2095297122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.